Clinical Trials Arena October 4, 2024
Jenna Philpott

Blood samples from over 500 newborn babies have already been collected across 13 NHS hospitals in England.

England’s National Health Service (NHS) has kick started a study which will screen up to 100,000 newborn babies for over 200 rare diseases.

The Generation Study – led by Genomics England in collaboration with NHS England – will offer whole genome sequencing to newborns using blood samples typically collected from their umbilical cord shortly after birth.

Parents of newborns in England are currently offered a blood spot test when their baby is about five days old. This test, performed with a small heel prick on the baby’s heel, screens for nine rare but serious conditions. However, the genetic sequencing used in...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Clinical Trials, Health System / Hospital, Provider, Trends
Binghampton University, Mayo Clinic and Others Snare NIH Funding for IBD Research
'Operational rigor' boosts ProMedica's Q3 margin to 4%, says CFO
Systems shift care models to bring in more APPs
UPMC, Vanderbilt join Aegis Ventures in digital consortium
Providence's CEO transition: What will make it work?

Share This Article